Clinical Trials Directory

Trials / Completed

CompletedNCT01149577

Effect of Olanzapine on Sleep Electroencephalogram (EEG) in Schizophrenia Patients

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Central Institute of Psychiatry, Ranchi, India · Academic / Other
Sex
Male
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Acute and sub-chronic administration of olanzapine has shown a favourable effect on the sleep disturbances in previously medicated schizophrenia patients with predominantly negative symptoms. The present study will be carried out to clarify the effect of olanzapine on polysomnographic profiles of schizophrenia patients in an acute phase of illness after controlling for the drug effects.

Detailed description

Twenty schizophrenia patients (11 drug naïve and 9 drug free) will be studied over a period of six weeks of olanzapine treatment. Patients will be assessed at the baseline on BPRS, PANSS, CDSS and UKU side effect rating scales and a baseline 40 channels polysomnography will be done. After the initial assessment, patients will put on olanzapine treatment, in flexible dosages based on clinical response, for a period of six weeks when a final assessment on clinical rating scales and polysomnography will be done. The sleep data will be scored manually for staging based on Rechtschaffen and Kales criteria.

Conditions

Interventions

TypeNameDescription
DRUGOlanzapine06 weeks treatment with Olanzapine in a flexible dosage schedule.

Timeline

Start date
2007-08-01
Primary completion
2007-12-01
Completion
2009-04-01
First posted
2010-06-23
Last updated
2010-06-23

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT01149577. Inclusion in this directory is not an endorsement.